Unlocking the potential of natural products in drug discovery
- PMID: 30565871
- PMCID: PMC6302737
- DOI: 10.1111/1751-7915.13351
Unlocking the potential of natural products in drug discovery
Abstract
The natural product specialized metabolites produced by microbes and plants are the backbone of our current drugs. Despite their historical importance, few pharmaceutical companies currently emphasize their exploitation in new drug discovery and instead favour synthetic compounds as more tractable alternatives. Ironically, we are in a Golden Age of understanding of natural product biosynthesis, biochemistry and engineering. These advances have the potential to usher in a new era of natural product exploration and development taking full advantage of the unique and favourable properties of natural products compounds in drug discovery.
© 2018 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology.
References
-
- Chen, J. , Wu, Q. , Hawas, U.W. , and Wang, H. (2016) Genetic regulation and manipulation for natural product discovery. Appl Microbiol Biotechnol 100: 2953–2965. - PubMed
-
- Katz, M. , Hover, B.M. , and Brady, S.F. (2016) Culture‐independent discovery of natural products from soil metagenomes. J Ind Microbiol Biotechnol 43: 129–141. - PubMed
-
- Leung, A.Y. (2006) Traditional toxicity documentation of Chinese Materia Medica–an overview. Toxicol Pathol 34: 319–326. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
